SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024084
Filing Date
2021-05-05
Accepted
2021-05-05 16:19:08
Documents
65
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rcus-10q_20210331.htm   iXBRL 10-Q 1991950
2 EX-10.2 rcus-ex102_91.htm EX-10.2 179156
3 EX-31.1 rcus-ex311_6.htm EX-31.1 21139
4 EX-31.2 rcus-ex312_9.htm EX-31.2 21031
5 EX-32.1 rcus-ex321_7.htm EX-32.1 9211
6 EX-32.2 rcus-ex322_10.htm EX-32.2 9239
  Complete submission text file 0001564590-21-024084.txt   7213997

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA rcus-20210331.xsd EX-101.SCH 61715
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rcus-20210331_cal.xml EX-101.CAL 44284
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rcus-20210331_def.xml EX-101.DEF 165367
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rcus-20210331_lab.xml EX-101.LAB 409547
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rcus-20210331_pre.xml EX-101.PRE 304096
12 EXTRACTED XBRL INSTANCE DOCUMENT rcus-10q_20210331_htm.xml XML 1120484
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38419 | Film No.: 21893602
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences